SOHO 2022 Tenth Annual Meeting

 

SOHO 2022 Tenth Annual Meeting
S

SOHO 2022: Long-Term Outcomes After Haplo-SCT for Hematologic Malignancies

By SOHO 2022 Tenth Annual Meeting FEATURING Supawee Saengboon
By SOHO 2022 Tenth Annual Meeting FEATURING Supawee Saengboon
137 views
October 17, 2022
Comments 0
Login to view comments. Click here to Login

Featured Video

11:12
Stemline

A proven CD123 targeted therapy for BPDCN

Feat. H. Erba

Featured Video

16:26
Incyte

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison
Leukemia
06:06

SOHO 2022: Characteristics of Patients With Myelofibrosis Taking Rux…

SOHO 2022 Tenth Annual Meeting

L. Masarova

56 views
16:50

SOHO 2022: Role of ddPCR in CML Today

SOHO 2022 Tenth Annual Meeting

J. Radich, S. Soverini

23 views
15:48

SOHO 2022: State of the Art in CML

SOHO 2022 Tenth Annual Meeting

M. Deininger, G. Saglio

247 views
08:51

SOHO 2022: Long-Term Outcomes After Haplo-SCT for Hematologic Malign…

SOHO 2022 Tenth Annual Meeting

S. Saengboon

137 views
09:22

GLOW Study - First Prospective Data on MRD Outcomes After Fixed-Dura…

SOHO 2022 Tenth Annual Meeting

C. Owen

102 views
09:54

SOHO 2022 Next Questions: CML

SOHO 2022 Tenth Annual Meeting

T. Hughes

72 views
08:27

SOHO 2022 Next Questions: CLL

SOHO 2022 Tenth Annual Meeting

F. Cymbalista

39 views
12:33

SOHO 2022 Next Questions: AML

SOHO 2022 Tenth Annual Meeting

H. Kantarjian

1.7K views
10:33

Next Questions: ALL

Lori Muffly

142 views
11:20

SOHO 2022: Orca-T Results in High GVHD-Free and Relapse-Free Surviva…

SOHO 2022 Tenth Annual Meeting

S. Srour

13 views
15:25

Supportive Therapy in CLL

SOHO 2022 Tenth Annual Meeting

C. Sun

60 views
14:10

CLL - Real World Data With Small Molecules

SOHO 2022 Tenth Annual Meeting

F. Cymbalista

68 views
14:13

CLL DEBATE: How Many Drugs Are Needed in 1L CLL?

SOHO 2022 Tenth Annual Meeting

A. Mato

96 views
15:03

CLL DEBATE: Combination Small Molecules vs. Sequencing in CLL - Pro …

SOHO 2022 Tenth Annual Meeting

J. Brown

94 views
13:53

SOHO 2022: Covalent BTK Inhibitors - How Do They Compare in CLL?

SOHO 2022 Tenth Annual Meeting

J. Byrd

43 views
15:10

Clinical Significance of B-Cell Receptor Stereotypy in CLL

SOHO 2022 Tenth Annual Meeting

K. Stamatopoulos

59 views
10:34

SOHO 2022: PACE and OPTIC Trials - Dose Modification Dynamics of Pon…

SOHO 2022 Tenth Annual Meeting

H. Kantarjian

73 views
16:33

SOHO 2022: Asciminib or Ponatinib for Multiresistant CML Patients?

SOHO 2022 Tenth Annual Meeting

J. Cortés

34 views
14:57

SOHO 2022: Immunotherapy - The Way Forward to Maximize TFR in CML?

SOHO 2022 Tenth Annual Meeting

D. Rea

9 views
13:34

SOHO 2022: Beyond TKI Therapy in CML

SOHO 2022 Tenth Annual Meeting

M. Copland

14 views
09:52

SOHO 2022: AGILE - A Phase 3, Global, Randomized, Double-Blind Study…

SOHO 2022 Tenth Annual Meeting

A. de la Fuente, C. DiNardo

19 views
16:04

SOHO 2022: Emerging CAR T-Cell Therapy Approaches in AML

SOHO 2022 Tenth Annual Meeting

S. Kenderian

31 views
15:39

SOHO 2022 AML DEBATE: Is MRD More Prognostic Than Initial Presentati…

SOHO 2022 Tenth Annual Meeting

C. Lindsley

17 views
16:37

SOHO 2022 AML DEBATE: Is MRD More Prognostic Than Initial Presentati…

SOHO 2022 Tenth Annual Meeting

M. Heuser

14 views
14:41

Is the Future of AML Therapy All Oral?

Farhad Ravandi

160 views
14:50

SOHO 2022: Non-Intensive Treatment of Elderly/Unfit Patients With AML

SOHO 2022 Tenth Annual Meeting

T. Kadia

28 views
15:45

SOHO 2022: How Do We Overcome Resistance to Venetoclax in AML

SOHO 2022 Tenth Annual Meeting

M. Konopleva

884 views
15:21

SOHO 2022: FLT3-Mutated AML - Triplet vs. Doublet Therapy

SOHO 2022 Tenth Annual Meeting

E. Wang

26 views
15:13

SOHO 2022: Menin Inhibitors in AML

SOHO 2022 Tenth Annual Meeting

E. Stein

213 views
17:07

SOHO 2022: Novel Chemotherapy Can Eliminate the Need for Transplant …

SOHO 2022 Tenth Annual Meeting

N. Short

64 views
11:49

SOHO 2022: Certain Patients With ALL Still Need a Transplant

SOHO 2022 Tenth Annual Meeting

J. Ribera, P. Scheinberg

14 views
15:52

SOHO 2022: Approach to ALL in the Elderly

SOHO 2022 Tenth Annual Meeting

M. Luskin

26 views
13:46

SOHO 2022: Management of Ph+ ALL in 2022

SOHO 2022 Tenth Annual Meeting

E. Jabbour

127 views
06:35

SOHO 2022: Phase II Study of Blinatumomab in Combination With Ponati…

SOHO 2022 Tenth Annual Meeting

F. Haddad

79 views

SOHO 2022: Dual Targeted CAR T-Cells for ALL

SOHO 2022 Tenth Annual Meeting

N. Frey

10 views
12:49

SOHO 2022: Approach to Ph-Like ALL

SOHO 2022 Tenth Annual Meeting

E. Curran

34 views
16:13

SOHO 2022: Blinatumomab in Pediatric ALL

SOHO 2022 Tenth Annual Meeting

S. Cooper

42 views
12:06

New BTKi in CLL

Catherine Coombs

248 views
09:23

Novel Agents in CLL

SOHO 2022 Tenth Annual Meeting

A. Danilov

66 views
11:07

SOHO 2022: BCL2i in CLL

SOHO 2022 Tenth Annual Meeting

A. Chanan-Khan

83 views
08:48

SOHO 2022: Childhood CML

SOHO 2022 Tenth Annual Meeting

F. Millot

11 views
20:12

SOHO 2022: Assessment and Management of TKI-Related AOEs in CML

SOHO 2022 Tenth Annual Meeting

G. Saglio

26 views
13:09

SOHO 2022: Non BCR-ABL Mutations in CML - Do They Matter?

SOHO 2022 Tenth Annual Meeting

S. Soverini

21 views
15:43

SOHO 2022: Advances in ALL Diagnosis and Treatment - The NOPHO Exper…

SOHO 2022 Tenth Annual Meeting

K. Schmiegelow

15 views
09:08

Approaches to and Use of MRD in ALL

Selina Luger

75 views
11:13

SOHO 2022: Allogeneic CAR T-Cells in ALL

SOHO 2022 Tenth Annual Meeting

N. Jain

26 views
12:26

SOHO 2022: Is TP53-Mutated AML the Same Disease as TP53-Mutated MDS?

SOHO 2022 Tenth Annual Meeting

P. Valk

37 views
19:33

SOHO 2022 Update on CD47 Targeting Antibodies

SOHO 2022 Tenth Annual Meeting

N. Daver

33 views
20:35

SOHO 2022: What Is the Best Strategy for Therapy-Related AML?

SOHO 2022 Tenth Annual Meeting

P. Desai

47 views